Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_23148 details
Primary information
SALIDSAL_23148
Biomarker namehsa-miR-31
Biomarker TypeNA
Sampling MethodSaliva was collected a week before surgery from 45 patients with OSCC and from 24 healthy individuals matched by age, sex, and oral habits served as controls.
Collection Method3-5 ml of saliva were collected from the mouth floor after simple mouth rinsing. After centrifugation, the supernatant was aliquoted and preserved at 80 degree celcius.
Analysis MethodqRT-PCR
Collection SiteSupernatant Saliva
Disease CategoryHealthy
Disease/ConditionNA
Disease SubtypeHealthy
Fold Change/ ConcentrationNA
Up/DownregulatedNA
ExosomalNA
OrganismHomo sapiens
PMID22083872
Year of Publication2012
Biomarker IDhsa-miR-31
Biomarker CategorymiRNA
SequenceGGAGAGGAGGCAAGAUGCUGGCAUAGCUGUUGAACUGGGAACCUGCUAUGCCAACAUAUUGCCAUCUUUCC
Title of studyExploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma
Abstract of studyBACKGROUND: Oral carcinoma is an important malignancy throughout the world. MicroRNAs (miRNAs) are endogenously expressed, non-coding RNAs that regulate post-transcriptional levels of targeted mRNAs. MiRNA-31(miR-31) is significantly upregulated in oral carcinoma tissues and plays oncogenic roles in oral carcinogenesis.METHODS: We analyzed the levels of miR-31 in saliva of patients with oral carcinoma (n = 45), oral verrucous leukoplakia (n = 10), and control healthy individuals (n = 24) by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Salivary miR-31 was significantly increased in patients with oral carcinoma at all clinical stages, including very small tumors. However, our preliminary analysis showed no increase of salivary miR-31 in patients with oral verrucous leukoplakia relative to controls. The miR-31 was more abundant in saliva than in plasma, suggesting salivary miR-31 was a more sensitive marker for oral malignancy. After excision of oral carcinoma, salivary miR-31 was remarkably reduced, indicating that most of the upregulated salivary miR-31 came from tumor tissues.CONCLUSION: Our results point to a potential application of salivary miR-31 as a biomarker for early detection and postoperative follow-up of oral carcinoma.